Physician profile
Sonya E Leck
NPI 1881669232
$1,629.35
in general payments reported to CMS, 2019-2025
24 companies · $671 in 2025
The $671 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $79.07 · 2024: $879 · 2025: $671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $297.34 | 2023-2024 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $176.52 | 2024 | Repatha, Otezla, Prolia |
| Novo Nordisk INC | $147.77 | 2024-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $144.08 | 2024-2025 | Mounjaro, Zepbound, Kisunla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.29 | 2024-2025 | Jardiance |
| Sumitomo Pharma America, INC. | $124.95 | 2024-2025 | Gemtesa |
| Idorsia Pharmaceuticals US INC | $114.31 | 2024-2025 | Quviviq, Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $61.44 | 2024-2025 | |
| Axsome Therapeutics, INC. | $60.38 | 2025 | Sunosi |
| Pfizer INC. | $51.50 | 2024 | |
| Medtronic, INC. | $43.15 | 2023-2025 | Intellis Adaptivestim, Endurant Iis |
| Abbvie INC. | $35.71 | 2024-2025 | |
| Abbott Laboratories | $32.26 | 2024-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $30.12 | 2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $25.20 | 2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $21.73 | 2025 | |
| Glaxosmithkline, LLC. | $19.92 | 2025 | Trelegy Ellipta |
| Dynavax Technologies Corporation | $19.21 | 2025 | Heplisav-B |
| Surmodics, INC. | $18.89 | 2023 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Pounce Thrombectomy System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.68 | 2024 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.60 | 2025 | Caplyta |
| Chiesi USA, INC. | $16.36 | 2023 | Kengreal, Cleviprex |
| Esperion Therapeutics, INC. | $14.44 | 2024 | Nexletol |
| Exact Sciences Corporation | $13.50 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Leck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.